Regional Tuberculosis (TB) Diagnostic and Resistance Data – July–September 2024
| dc.contributor.author | Tigray Health Research Institue | |
| dc.date.accessioned | 2025-08-17T16:40:16Z | |
| dc.date.issued | 2025-08-17 | |
| dc.description.abstract | This dataset presents regional Mycobacterium tuberculosis (MTB) diagnostic and resistance data for July–September 2024, covering: Rifampicin Mono Resistance Cases (N = 14): Disaggregated by sex and treatment (Rx) history GeneXpert Tests (N = 7,241): Monthly testing volumes throughout 2024 MTB Positivity Rates (N = 560): Stratified by age category, HIV status, gender, Rx history, and site of infection The data enable analysis of regional MTB trends, treatment-resistance patterns, and demographic or clinical factors linked to positivity rates | |
| dc.identifier.uri | https://rdmcrepo.thri.gov.et/handle/123456789/279 | |
| dc.identifier.uri | https://api.datacite.org/10.82208/trdmc-363 | |
| dc.language.iso | en_US | |
| dc.publisher | TRDMC | |
| dc.title | Regional Tuberculosis (TB) Diagnostic and Resistance Data – July–September 2024 | |
| dc.type | Dataset |